HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of clinical trials in changing therapy for ductal carcinoma in situ.

Abstract
Some aspects of the diagnosis of ductal carcinoma in situ (DCIS) are well established, but consideration of other variables may be critical to optimize treatment. Mastectomy was once standard surgery, to reduce the probability of invasive breast carcinoma recurrence (to < 1%). However, the ability to control DCIS to a comparable extent but without resorting to mastectomy has been a major goal. There are indications from clinical studies that excision plus radiation therapy is as effective as mastectomy in reducing recurrence in patients with low-risk DCIS. Furthermore, following surgery and irradiation with long-term endocrine therapy appears to further reduce the risk of local DCIS progression. Variables that should be considered in making a treatment decision are extent of disease within the breast, nuclear grade of the lesion, age of the patient, and margin of surgical excision. Several randomized trials are currently evaluating the clinical value of these variables in optimizing treatment for patients with low-risk DCIS. Future improvements in treatment may depend on more sophisticated cellular and molecular markers of disease extent and prognosis at diagnosis.
AuthorsWilliam C Wood
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 11 Issue 1 Suppl Pg. 24S-27S (Jan 2004) ISSN: 1068-9265 [Print] United States
PMID15015706 (Publication Type: Journal Article)
Topics
  • Breast Neoplasms (diagnostic imaging, drug therapy, prevention & control, therapy)
  • Carcinoma, Intraductal, Noninfiltrating (diagnostic imaging, drug therapy, prevention & control, therapy)
  • Clinical Trials as Topic
  • Female
  • Humans
  • Mammography
  • Mastectomy, Segmental

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: